nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—ABCB1—melanoma	0.00483	1	CrCbGaD
Nabilone—Nasal congestion—Temozolomide—melanoma	0.00299	0.00612	CcSEcCtD
Nabilone—Eye irritation—Docetaxel—melanoma	0.00292	0.00598	CcSEcCtD
Nabilone—Hot flush—Temozolomide—melanoma	0.00291	0.00596	CcSEcCtD
Nabilone—Menopausal symptoms—Temozolomide—melanoma	0.00289	0.00591	CcSEcCtD
Nabilone—Thirst—Temozolomide—melanoma	0.00286	0.00586	CcSEcCtD
Nabilone—Cough—Vemurafenib—melanoma	0.0028	0.00573	CcSEcCtD
Nabilone—Myalgia—Vemurafenib—melanoma	0.00273	0.00559	CcSEcCtD
Nabilone—Arthralgia—Vemurafenib—melanoma	0.00273	0.00559	CcSEcCtD
Nabilone—Face oedema—Carmustine—melanoma	0.00272	0.00557	CcSEcCtD
Nabilone—Drug interaction—Docetaxel—melanoma	0.00269	0.00551	CcSEcCtD
Nabilone—Affect lability—Temozolomide—melanoma	0.00268	0.00549	CcSEcCtD
Nabilone—Ataxia—Carmustine—melanoma	0.00265	0.00543	CcSEcCtD
Nabilone—Face oedema—Temozolomide—melanoma	0.00263	0.00538	CcSEcCtD
Nabilone—Infection—Vemurafenib—melanoma	0.0026	0.00533	CcSEcCtD
Nabilone—Mood swings—Temozolomide—melanoma	0.00258	0.00528	CcSEcCtD
Nabilone—Ataxia—Temozolomide—melanoma	0.00256	0.00524	CcSEcCtD
Nabilone—Hypotension—Vemurafenib—melanoma	0.00245	0.00501	CcSEcCtD
Nabilone—Stomatitis—Bleomycin—melanoma	0.00243	0.00497	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00239	0.00489	CcSEcCtD
Nabilone—Sweating increased—Temozolomide—melanoma	0.00229	0.00469	CcSEcCtD
Nabilone—Decreased appetite—Vemurafenib—melanoma	0.00228	0.00466	CcSEcCtD
Nabilone—Stomatitis—Dactinomycin—melanoma	0.00226	0.00463	CcSEcCtD
Nabilone—Fatigue—Vemurafenib—melanoma	0.00226	0.00462	CcSEcCtD
Nabilone—Constipation—Vemurafenib—melanoma	0.00224	0.00459	CcSEcCtD
Nabilone—Lightheadedness—Docetaxel—melanoma	0.00223	0.00457	CcSEcCtD
Nabilone—Hypoaesthesia—Bleomycin—melanoma	0.00222	0.00455	CcSEcCtD
Nabilone—Pollakiuria—Temozolomide—melanoma	0.00217	0.00445	CcSEcCtD
Nabilone—Depression—Carmustine—melanoma	0.00217	0.00443	CcSEcCtD
Nabilone—Photosensitivity reaction—Temozolomide—melanoma	0.00215	0.0044	CcSEcCtD
Nabilone—Stomatitis—Carmustine—melanoma	0.00212	0.00433	CcSEcCtD
Nabilone—Depression—Temozolomide—melanoma	0.00209	0.00429	CcSEcCtD
Nabilone—Flushing—Bleomycin—melanoma	0.00207	0.00424	CcSEcCtD
Nabilone—Body temperature increased—Vemurafenib—melanoma	0.00207	0.00424	CcSEcCtD
Nabilone—Pharyngitis—Dactinomycin—melanoma	0.00207	0.00423	CcSEcCtD
Nabilone—Stomatitis—Temozolomide—melanoma	0.00205	0.00419	CcSEcCtD
Nabilone—Chills—Bleomycin—melanoma	0.002	0.0041	CcSEcCtD
Nabilone—Hallucination—Carmustine—melanoma	0.00194	0.00397	CcSEcCtD
Nabilone—Hypoaesthesia—Carmustine—melanoma	0.00194	0.00397	CcSEcCtD
Nabilone—Hot flush—Docetaxel—melanoma	0.00194	0.00396	CcSEcCtD
Nabilone—Flushing—Dactinomycin—melanoma	0.00193	0.00396	CcSEcCtD
Nabilone—Hypersensitivity—Vemurafenib—melanoma	0.00193	0.00395	CcSEcCtD
Nabilone—Menopausal symptoms—Docetaxel—melanoma	0.00192	0.00393	CcSEcCtD
Nabilone—Visual disturbance—Docetaxel—melanoma	0.00191	0.00391	CcSEcCtD
Nabilone—Asthenia—Vemurafenib—melanoma	0.00188	0.00385	CcSEcCtD
Nabilone—Visual impairment—Carmustine—melanoma	0.00188	0.00385	CcSEcCtD
Nabilone—Hypoaesthesia—Temozolomide—melanoma	0.00187	0.00384	CcSEcCtD
Nabilone—Hallucination—Temozolomide—melanoma	0.00187	0.00384	CcSEcCtD
Nabilone—Pharyngitis—Temozolomide—melanoma	0.00187	0.00383	CcSEcCtD
Nabilone—Chills—Dactinomycin—melanoma	0.00187	0.00383	CcSEcCtD
Nabilone—Pruritus—Vemurafenib—melanoma	0.00185	0.00379	CcSEcCtD
Nabilone—Eye disorder—Carmustine—melanoma	0.00182	0.00373	CcSEcCtD
Nabilone—Visual impairment—Temozolomide—melanoma	0.00182	0.00372	CcSEcCtD
Nabilone—Flushing—Carmustine—melanoma	0.00181	0.0037	CcSEcCtD
Nabilone—Ill-defined disorder—Bleomycin—melanoma	0.0018	0.00369	CcSEcCtD
Nabilone—Anaemia—Bleomycin—melanoma	0.0018	0.00368	CcSEcCtD
Nabilone—Diarrhoea—Vemurafenib—melanoma	0.00179	0.00367	CcSEcCtD
Nabilone—Eye disorder—Temozolomide—melanoma	0.00176	0.00361	CcSEcCtD
Nabilone—Tinnitus—Temozolomide—melanoma	0.00176	0.0036	CcSEcCtD
Nabilone—Malaise—Bleomycin—melanoma	0.00175	0.00359	CcSEcCtD
Nabilone—Flushing—Temozolomide—melanoma	0.00175	0.00358	CcSEcCtD
Nabilone—Arrhythmia—Carmustine—melanoma	0.00174	0.00357	CcSEcCtD
Nabilone—Leukopenia—Bleomycin—melanoma	0.00174	0.00356	CcSEcCtD
Nabilone—Dizziness—Vemurafenib—melanoma	0.00173	0.00355	CcSEcCtD
Nabilone—Ataxia—Docetaxel—melanoma	0.0017	0.00349	CcSEcCtD
Nabilone—Cough—Bleomycin—melanoma	0.0017	0.00347	CcSEcCtD
Nabilone—Chills—Temozolomide—melanoma	0.00169	0.00346	CcSEcCtD
Nabilone—Ill-defined disorder—Dactinomycin—melanoma	0.00168	0.00345	CcSEcCtD
Nabilone—Anaemia—Dactinomycin—melanoma	0.00168	0.00343	CcSEcCtD
Nabilone—Vomiting—Vemurafenib—melanoma	0.00167	0.00341	CcSEcCtD
Nabilone—Myalgia—Bleomycin—melanoma	0.00166	0.00339	CcSEcCtD
Nabilone—Chest pain—Bleomycin—melanoma	0.00166	0.00339	CcSEcCtD
Nabilone—Orthostatic hypotension—Docetaxel—melanoma	0.00165	0.00339	CcSEcCtD
Nabilone—Rash—Vemurafenib—melanoma	0.00165	0.00338	CcSEcCtD
Nabilone—Dermatitis—Vemurafenib—melanoma	0.00165	0.00338	CcSEcCtD
Nabilone—Back pain—Carmustine—melanoma	0.00164	0.00336	CcSEcCtD
Nabilone—Headache—Vemurafenib—melanoma	0.00164	0.00336	CcSEcCtD
Nabilone—Discomfort—Bleomycin—melanoma	0.00164	0.00335	CcSEcCtD
Nabilone—Malaise—Dactinomycin—melanoma	0.00164	0.00335	CcSEcCtD
Nabilone—Leukopenia—Dactinomycin—melanoma	0.00162	0.00332	CcSEcCtD
Nabilone—Confusional state—Bleomycin—melanoma	0.0016	0.00328	CcSEcCtD
Nabilone—Vision blurred—Carmustine—melanoma	0.0016	0.00328	CcSEcCtD
Nabilone—Tremor—Carmustine—melanoma	0.00159	0.00326	CcSEcCtD
Nabilone—Back pain—Temozolomide—melanoma	0.00159	0.00325	CcSEcCtD
Nabilone—Infection—Bleomycin—melanoma	0.00158	0.00323	CcSEcCtD
Nabilone—Anaemia—Carmustine—melanoma	0.00157	0.00321	CcSEcCtD
Nabilone—Agitation—Carmustine—melanoma	0.00156	0.00319	CcSEcCtD
Nabilone—Nausea—Vemurafenib—melanoma	0.00156	0.00319	CcSEcCtD
Nabilone—Vision blurred—Temozolomide—melanoma	0.00155	0.00316	CcSEcCtD
Nabilone—Myalgia—Dactinomycin—melanoma	0.00154	0.00316	CcSEcCtD
Nabilone—Tremor—Temozolomide—melanoma	0.00154	0.00315	CcSEcCtD
Nabilone—Discomfort—Dactinomycin—melanoma	0.00153	0.00312	CcSEcCtD
Nabilone—Ill-defined disorder—Temozolomide—melanoma	0.00152	0.00312	CcSEcCtD
Nabilone—Leukopenia—Carmustine—melanoma	0.00152	0.00311	CcSEcCtD
Nabilone—Anaemia—Temozolomide—melanoma	0.00152	0.0031	CcSEcCtD
Nabilone—Anorexia—Bleomycin—melanoma	0.00151	0.0031	CcSEcCtD
Nabilone—Agitation—Temozolomide—melanoma	0.00151	0.00309	CcSEcCtD
Nabilone—Hypotension—Bleomycin—melanoma	0.00148	0.00304	CcSEcCtD
Nabilone—Malaise—Temozolomide—melanoma	0.00148	0.00303	CcSEcCtD
Nabilone—Vertigo—Temozolomide—melanoma	0.00147	0.00302	CcSEcCtD
Nabilone—Convulsion—Carmustine—melanoma	0.00147	0.00301	CcSEcCtD
Nabilone—Infection—Dactinomycin—melanoma	0.00147	0.00301	CcSEcCtD
Nabilone—Leukopenia—Temozolomide—melanoma	0.00147	0.00301	CcSEcCtD
Nabilone—Hypertension—Carmustine—melanoma	0.00147	0.003	CcSEcCtD
Nabilone—Palpitations—Temozolomide—melanoma	0.00145	0.00297	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00145	0.00296	CcSEcCtD
Nabilone—Myalgia—Carmustine—melanoma	0.00144	0.00296	CcSEcCtD
Nabilone—Chest pain—Carmustine—melanoma	0.00144	0.00296	CcSEcCtD
Nabilone—Anxiety—Carmustine—melanoma	0.00144	0.00295	CcSEcCtD
Nabilone—Cough—Temozolomide—melanoma	0.00143	0.00293	CcSEcCtD
Nabilone—Paraesthesia—Bleomycin—melanoma	0.00142	0.00292	CcSEcCtD
Nabilone—Convulsion—Temozolomide—melanoma	0.00142	0.00291	CcSEcCtD
Nabilone—Hypertension—Temozolomide—melanoma	0.00142	0.0029	CcSEcCtD
Nabilone—Dyspnoea—Bleomycin—melanoma	0.00141	0.0029	CcSEcCtD
Nabilone—Anorexia—Dactinomycin—melanoma	0.00141	0.00289	CcSEcCtD
Nabilone—Confusional state—Carmustine—melanoma	0.0014	0.00286	CcSEcCtD
Nabilone—Arthralgia—Temozolomide—melanoma	0.0014	0.00286	CcSEcCtD
Nabilone—Myalgia—Temozolomide—melanoma	0.0014	0.00286	CcSEcCtD
Nabilone—Anxiety—Temozolomide—melanoma	0.00139	0.00285	CcSEcCtD
Nabilone—Discomfort—Temozolomide—melanoma	0.00138	0.00282	CcSEcCtD
Nabilone—Decreased appetite—Bleomycin—melanoma	0.00138	0.00282	CcSEcCtD
Nabilone—Infection—Carmustine—melanoma	0.00138	0.00282	CcSEcCtD
Nabilone—Dry mouth—Temozolomide—melanoma	0.00137	0.0028	CcSEcCtD
Nabilone—Stomatitis—Docetaxel—melanoma	0.00136	0.00279	CcSEcCtD
Nabilone—Pain—Bleomycin—melanoma	0.00136	0.00278	CcSEcCtD
Nabilone—Tachycardia—Carmustine—melanoma	0.00135	0.00277	CcSEcCtD
Nabilone—Confusional state—Temozolomide—melanoma	0.00135	0.00276	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00135	0.00276	CcSEcCtD
Nabilone—Infection—Temozolomide—melanoma	0.00133	0.00272	CcSEcCtD
Nabilone—Anorexia—Carmustine—melanoma	0.00132	0.0027	CcSEcCtD
Nabilone—Epistaxis—Docetaxel—melanoma	0.00132	0.0027	CcSEcCtD
Nabilone—Feeling abnormal—Bleomycin—melanoma	0.00131	0.00268	CcSEcCtD
Nabilone—Hypotension—Carmustine—melanoma	0.00129	0.00265	CcSEcCtD
Nabilone—Hyperhidrosis—Temozolomide—melanoma	0.00129	0.00265	CcSEcCtD
Nabilone—Decreased appetite—Dactinomycin—melanoma	0.00129	0.00263	CcSEcCtD
Nabilone—Fatigue—Dactinomycin—melanoma	0.00128	0.00261	CcSEcCtD
Nabilone—Anorexia—Temozolomide—melanoma	0.00128	0.00261	CcSEcCtD
Nabilone—Pain—Dactinomycin—melanoma	0.00127	0.00259	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Carmustine—melanoma	0.00126	0.00258	CcSEcCtD
Nabilone—Body temperature increased—Bleomycin—melanoma	0.00125	0.00257	CcSEcCtD
Nabilone—Insomnia—Carmustine—melanoma	0.00125	0.00257	CcSEcCtD
Nabilone—Hypoaesthesia—Docetaxel—melanoma	0.00125	0.00255	CcSEcCtD
Nabilone—Paraesthesia—Carmustine—melanoma	0.00124	0.00255	CcSEcCtD
Nabilone—Pharyngitis—Docetaxel—melanoma	0.00124	0.00255	CcSEcCtD
Nabilone—Dyspnoea—Carmustine—melanoma	0.00123	0.00253	CcSEcCtD
Nabilone—Somnolence—Carmustine—melanoma	0.00123	0.00252	CcSEcCtD
Nabilone—Feeling abnormal—Dactinomycin—melanoma	0.00122	0.0025	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00122	0.0025	CcSEcCtD
Nabilone—Insomnia—Temozolomide—melanoma	0.00121	0.00248	CcSEcCtD
Nabilone—Gastrointestinal pain—Dactinomycin—melanoma	0.00121	0.00248	CcSEcCtD
Nabilone—Visual impairment—Docetaxel—melanoma	0.00121	0.00247	CcSEcCtD
Nabilone—Decreased appetite—Carmustine—melanoma	0.0012	0.00247	CcSEcCtD
Nabilone—Paraesthesia—Temozolomide—melanoma	0.0012	0.00246	CcSEcCtD
Nabilone—Dyspnoea—Temozolomide—melanoma	0.00119	0.00244	CcSEcCtD
Nabilone—Somnolence—Temozolomide—melanoma	0.00119	0.00244	CcSEcCtD
Nabilone—Pain—Carmustine—melanoma	0.00118	0.00243	CcSEcCtD
Nabilone—Constipation—Carmustine—melanoma	0.00118	0.00243	CcSEcCtD
Nabilone—Dyspepsia—Temozolomide—melanoma	0.00118	0.00241	CcSEcCtD
Nabilone—Eye disorder—Docetaxel—melanoma	0.00117	0.0024	CcSEcCtD
Nabilone—Abdominal pain—Dactinomycin—melanoma	0.00117	0.0024	CcSEcCtD
Nabilone—Body temperature increased—Dactinomycin—melanoma	0.00117	0.0024	CcSEcCtD
Nabilone—Hypersensitivity—Bleomycin—melanoma	0.00117	0.00239	CcSEcCtD
Nabilone—Decreased appetite—Temozolomide—melanoma	0.00116	0.00238	CcSEcCtD
Nabilone—Flushing—Docetaxel—melanoma	0.00116	0.00238	CcSEcCtD
Nabilone—Fatigue—Temozolomide—melanoma	0.00115	0.00236	CcSEcCtD
Nabilone—Constipation—Temozolomide—melanoma	0.00114	0.00234	CcSEcCtD
Nabilone—Pain—Temozolomide—melanoma	0.00114	0.00234	CcSEcCtD
Nabilone—Feeling abnormal—Carmustine—melanoma	0.00114	0.00234	CcSEcCtD
Nabilone—Asthenia—Bleomycin—melanoma	0.00114	0.00233	CcSEcCtD
Nabilone—Gastrointestinal pain—Carmustine—melanoma	0.00113	0.00232	CcSEcCtD
Nabilone—Chills—Docetaxel—melanoma	0.00112	0.0023	CcSEcCtD
Nabilone—Pruritus—Bleomycin—melanoma	0.00112	0.0023	CcSEcCtD
Nabilone—Arrhythmia—Docetaxel—melanoma	0.00112	0.00229	CcSEcCtD
Nabilone—Feeling abnormal—Temozolomide—melanoma	0.0011	0.00226	CcSEcCtD
Nabilone—Abdominal pain—Carmustine—melanoma	0.00109	0.00224	CcSEcCtD
Nabilone—Body temperature increased—Carmustine—melanoma	0.00109	0.00224	CcSEcCtD
Nabilone—Gastrointestinal pain—Temozolomide—melanoma	0.00109	0.00224	CcSEcCtD
Nabilone—Hypersensitivity—Dactinomycin—melanoma	0.00109	0.00223	CcSEcCtD
Nabilone—Asthenia—Dactinomycin—melanoma	0.00106	0.00217	CcSEcCtD
Nabilone—Abdominal pain—Temozolomide—melanoma	0.00106	0.00217	CcSEcCtD
Nabilone—Body temperature increased—Temozolomide—melanoma	0.00106	0.00217	CcSEcCtD
Nabilone—Back pain—Docetaxel—melanoma	0.00106	0.00216	CcSEcCtD
Nabilone—Hypersensitivity—Carmustine—melanoma	0.00102	0.00209	CcSEcCtD
Nabilone—Diarrhoea—Dactinomycin—melanoma	0.00101	0.00207	CcSEcCtD
Nabilone—Vomiting—Bleomycin—melanoma	0.00101	0.00207	CcSEcCtD
Nabilone—Anaemia—Docetaxel—melanoma	0.00101	0.00206	CcSEcCtD
Nabilone—Rash—Bleomycin—melanoma	0.001	0.00205	CcSEcCtD
Nabilone—Dermatitis—Bleomycin—melanoma	0.001	0.00205	CcSEcCtD
Nabilone—Asthenia—Carmustine—melanoma	0.000994	0.00203	CcSEcCtD
Nabilone—Hypersensitivity—Temozolomide—melanoma	0.000986	0.00202	CcSEcCtD
Nabilone—Syncope—Docetaxel—melanoma	0.000978	0.002	CcSEcCtD
Nabilone—Leukopenia—Docetaxel—melanoma	0.000976	0.002	CcSEcCtD
Nabilone—Palpitations—Docetaxel—melanoma	0.000964	0.00197	CcSEcCtD
Nabilone—Asthenia—Temozolomide—melanoma	0.00096	0.00197	CcSEcCtD
Nabilone—Loss of consciousness—Docetaxel—melanoma	0.000959	0.00196	CcSEcCtD
Nabilone—Cough—Docetaxel—melanoma	0.000952	0.00195	CcSEcCtD
Nabilone—Diarrhoea—Carmustine—melanoma	0.000948	0.00194	CcSEcCtD
Nabilone—Pruritus—Temozolomide—melanoma	0.000947	0.00194	CcSEcCtD
Nabilone—Convulsion—Docetaxel—melanoma	0.000945	0.00193	CcSEcCtD
Nabilone—Nausea—Bleomycin—melanoma	0.000943	0.00193	CcSEcCtD
Nabilone—Hypertension—Docetaxel—melanoma	0.000942	0.00193	CcSEcCtD
Nabilone—Vomiting—Dactinomycin—melanoma	0.000941	0.00193	CcSEcCtD
Nabilone—Rash—Dactinomycin—melanoma	0.000933	0.00191	CcSEcCtD
Nabilone—Arthralgia—Docetaxel—melanoma	0.000929	0.0019	CcSEcCtD
Nabilone—Myalgia—Docetaxel—melanoma	0.000929	0.0019	CcSEcCtD
Nabilone—Chest pain—Docetaxel—melanoma	0.000929	0.0019	CcSEcCtD
Nabilone—Dizziness—Carmustine—melanoma	0.000916	0.00188	CcSEcCtD
Nabilone—Diarrhoea—Temozolomide—melanoma	0.000916	0.00188	CcSEcCtD
Nabilone—Dry mouth—Docetaxel—melanoma	0.000908	0.00186	CcSEcCtD
Nabilone—Confusional state—Docetaxel—melanoma	0.000898	0.00184	CcSEcCtD
Nabilone—Dizziness—Temozolomide—melanoma	0.000885	0.00181	CcSEcCtD
Nabilone—Infection—Docetaxel—melanoma	0.000884	0.00181	CcSEcCtD
Nabilone—Vomiting—Carmustine—melanoma	0.000881	0.0018	CcSEcCtD
Nabilone—Nausea—Dactinomycin—melanoma	0.000879	0.0018	CcSEcCtD
Nabilone—Shock—Docetaxel—melanoma	0.000876	0.00179	CcSEcCtD
Nabilone—Rash—Carmustine—melanoma	0.000873	0.00179	CcSEcCtD
Nabilone—Dermatitis—Carmustine—melanoma	0.000873	0.00179	CcSEcCtD
Nabilone—Tachycardia—Docetaxel—melanoma	0.000869	0.00178	CcSEcCtD
Nabilone—Headache—Carmustine—melanoma	0.000868	0.00178	CcSEcCtD
Nabilone—Vomiting—Temozolomide—melanoma	0.000851	0.00174	CcSEcCtD
Nabilone—Anorexia—Docetaxel—melanoma	0.000849	0.00174	CcSEcCtD
Nabilone—Rash—Temozolomide—melanoma	0.000844	0.00173	CcSEcCtD
Nabilone—Dermatitis—Temozolomide—melanoma	0.000843	0.00173	CcSEcCtD
Nabilone—Headache—Temozolomide—melanoma	0.000839	0.00172	CcSEcCtD
Nabilone—Hypotension—Docetaxel—melanoma	0.000832	0.0017	CcSEcCtD
Nabilone—Nausea—Carmustine—melanoma	0.000823	0.00168	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000811	0.00166	CcSEcCtD
Nabilone—Insomnia—Docetaxel—melanoma	0.000805	0.00165	CcSEcCtD
Nabilone—Paraesthesia—Docetaxel—melanoma	0.000799	0.00164	CcSEcCtD
Nabilone—Nausea—Temozolomide—melanoma	0.000795	0.00163	CcSEcCtD
Nabilone—Dyspnoea—Docetaxel—melanoma	0.000794	0.00162	CcSEcCtD
Nabilone—Somnolence—Docetaxel—melanoma	0.000791	0.00162	CcSEcCtD
Nabilone—Dyspepsia—Docetaxel—melanoma	0.000784	0.0016	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—F2R—melanoma	0.000781	0.00154	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCR4—melanoma	0.000777	0.00153	CbGpPWpGaD
Nabilone—Decreased appetite—Docetaxel—melanoma	0.000774	0.00158	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—GNAQ—melanoma	0.000768	0.00152	CbGpPWpGaD
Nabilone—Fatigue—Docetaxel—melanoma	0.000767	0.00157	CcSEcCtD
Nabilone—Constipation—Docetaxel—melanoma	0.000761	0.00156	CcSEcCtD
Nabilone—Pain—Docetaxel—melanoma	0.000761	0.00156	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCR7—melanoma	0.000758	0.0015	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRM1—melanoma	0.000758	0.0015	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDNRB—melanoma	0.000756	0.00149	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SUFU—melanoma	0.000738	0.00146	CbGpPWpGaD
Nabilone—Feeling abnormal—Docetaxel—melanoma	0.000734	0.0015	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—F2RL1—melanoma	0.000729	0.00144	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Docetaxel—melanoma	0.000728	0.00149	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—GNA11—melanoma	0.000714	0.00141	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GAB2—melanoma	0.000714	0.00141	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT3—melanoma	0.000709	0.0014	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—F2R—melanoma	0.000709	0.0014	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—HRAS—melanoma	0.000706	0.00139	CbGpPWpGaD
Nabilone—Abdominal pain—Docetaxel—melanoma	0.000704	0.00144	CcSEcCtD
Nabilone—Body temperature increased—Docetaxel—melanoma	0.000704	0.00144	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—BCL2L11—melanoma	0.000689	0.00136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RHOB—melanoma	0.000689	0.00136	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDNRB—melanoma	0.000687	0.00136	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRM3—melanoma	0.000686	0.00135	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCR4—melanoma	0.000671	0.00132	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GNAQ—melanoma	0.000664	0.00131	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HDAC6—melanoma	0.000662	0.00131	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—EDN1—melanoma	0.000656	0.00129	CbGpPWpGaD
Nabilone—Hypersensitivity—Docetaxel—melanoma	0.000656	0.00134	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—KISS1—melanoma	0.00065	0.00128	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GNA11—melanoma	0.000649	0.00128	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GAB2—melanoma	0.000649	0.00128	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000647	0.00128	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CSF2—melanoma	0.000641	0.00127	CbGpPWpGaD
Nabilone—Asthenia—Docetaxel—melanoma	0.000639	0.00131	CcSEcCtD
Nabilone—Pruritus—Docetaxel—melanoma	0.00063	0.00129	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SKI—melanoma	0.00063	0.00124	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR1—melanoma	0.00063	0.00124	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCR2—melanoma	0.000628	0.00124	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—melanoma	0.000627	0.00124	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—AKT1—melanoma	0.000624	0.00123	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MC1R—melanoma	0.00062	0.00122	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAC2—melanoma	0.000618	0.00122	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PRKCA—melanoma	0.000615	0.00121	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT3—melanoma	0.000613	0.00121	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCR4—melanoma	0.00061	0.0012	CbGpPWpGaD
Nabilone—Diarrhoea—Docetaxel—melanoma	0.000609	0.00125	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—WNT5A—melanoma	0.000608	0.0012	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFC—melanoma	0.000608	0.0012	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GNAQ—melanoma	0.000603	0.00119	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EDN1—melanoma	0.000596	0.00118	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR7—melanoma	0.000595	0.00117	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRM1—melanoma	0.000595	0.00117	CbGpPWpGaD
Nabilone—Dizziness—Docetaxel—melanoma	0.000589	0.00121	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CSF2—melanoma	0.000582	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SUFU—melanoma	0.000579	0.00114	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—RAC1—melanoma	0.00057	0.00112	CbGpPWpGaD
Nabilone—Vomiting—Docetaxel—melanoma	0.000566	0.00116	CcSEcCtD
Nabilone—Rash—Docetaxel—melanoma	0.000561	0.00115	CcSEcCtD
Nabilone—Dermatitis—Docetaxel—melanoma	0.000561	0.00115	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PRKCA—melanoma	0.000558	0.0011	CbGpPWpGaD
Nabilone—Headache—Docetaxel—melanoma	0.000558	0.00114	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AKT3—melanoma	0.000556	0.0011	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAP2K2—melanoma	0.000546	0.00108	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RHOB—melanoma	0.000541	0.00107	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BCL2L11—melanoma	0.000541	0.00107	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—F2R—melanoma	0.000534	0.00105	CbGpPWpGaD
Nabilone—Nausea—Docetaxel—melanoma	0.000529	0.00108	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HDAC6—melanoma	0.00052	0.00103	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—RAC1—melanoma	0.000518	0.00102	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDNRB—melanoma	0.000517	0.00102	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDN1—melanoma	0.000515	0.00102	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CSF2—melanoma	0.000503	0.000993	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTK2B—melanoma	0.000502	0.00099	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR2—melanoma	0.000493	0.000972	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—melanoma	0.000492	0.000972	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GAB2—melanoma	0.000488	0.000963	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNA11—melanoma	0.000488	0.000963	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FLT1—melanoma	0.000486	0.000959	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAC2—melanoma	0.000485	0.000956	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PRKCA—melanoma	0.000482	0.000952	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—melanoma	0.000482	0.00095	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—WNT5A—melanoma	0.000477	0.000941	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFC—melanoma	0.000477	0.000941	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDN1—melanoma	0.000468	0.000922	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCR4—melanoma	0.000459	0.000906	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HDAC2—melanoma	0.000459	0.000906	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FOXO4—melanoma	0.000459	0.000906	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CSF2—melanoma	0.000457	0.000902	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNAQ—melanoma	0.000454	0.000896	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—RAC1—melanoma	0.000447	0.000883	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PRKCA—melanoma	0.000438	0.000864	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—melanoma	0.000437	0.000863	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAP2K2—melanoma	0.000428	0.000845	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SYK—melanoma	0.000427	0.000842	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CD—melanoma	0.000423	0.000835	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ITGAV—melanoma	0.000419	0.000827	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT3—melanoma	0.000419	0.000827	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NGFR—melanoma	0.000419	0.000827	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—F2R—melanoma	0.000419	0.000827	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RAC1—melanoma	0.000406	0.000801	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDNRB—melanoma	0.000406	0.000801	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTK2B—melanoma	0.000394	0.000777	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SOCS1—melanoma	0.000388	0.000765	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAP2K1—melanoma	0.000387	0.000764	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—S100B—melanoma	0.000387	0.000763	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CD—melanoma	0.000384	0.000759	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GAB2—melanoma	0.000383	0.000756	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNA11—melanoma	0.000383	0.000756	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FLT1—melanoma	0.000381	0.000753	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—melanoma	0.000378	0.000746	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB4—melanoma	0.00037	0.00073	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CB—melanoma	0.000369	0.000728	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN2B—melanoma	0.000367	0.000724	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR4—melanoma	0.00036	0.000711	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FOXO4—melanoma	0.00036	0.000711	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HDAC2—melanoma	0.00036	0.000711	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNAQ—melanoma	0.000356	0.000703	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CD86—melanoma	0.000355	0.0007	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—melanoma	0.000355	0.0007	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDN1—melanoma	0.000352	0.000694	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF1—melanoma	0.000344	0.000679	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CSF2—melanoma	0.000344	0.000679	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—melanoma	0.000343	0.000677	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IL2—melanoma	0.000339	0.000669	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—E2F1—melanoma	0.000337	0.000664	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CB—melanoma	0.000335	0.000661	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SYK—melanoma	0.000335	0.000661	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFRA—melanoma	0.000333	0.000657	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CD—melanoma	0.000332	0.000655	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ITGB3—melanoma	0.00033	0.000651	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKCA—melanoma	0.00033	0.000651	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ITGAV—melanoma	0.000329	0.000649	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NGFR—melanoma	0.000329	0.000649	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT3—melanoma	0.000329	0.000649	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—melanoma	0.000323	0.000638	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAP2K2—melanoma	0.000322	0.000636	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL8—melanoma	0.000322	0.000635	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL2—melanoma	0.000308	0.000607	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TERT—melanoma	0.000307	0.000605	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAC1—melanoma	0.000306	0.000603	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SOCS1—melanoma	0.000304	0.000601	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAP2K1—melanoma	0.000304	0.000599	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—S100B—melanoma	0.000304	0.000599	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CD—melanoma	0.000302	0.000595	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIF1A—melanoma	0.000293	0.000579	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB4—melanoma	0.00029	0.000573	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CB—melanoma	0.00029	0.000571	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN2B—melanoma	0.000288	0.000568	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KDR—melanoma	0.00028	0.000553	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CD86—melanoma	0.000278	0.000549	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—melanoma	0.000278	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDN1—melanoma	0.000276	0.000545	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FN1—melanoma	0.00027	0.000533	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF1—melanoma	0.00027	0.000533	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CSF2—melanoma	0.00027	0.000533	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—melanoma	0.000266	0.000525	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH1—melanoma	0.000264	0.000521	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—E2F1—melanoma	0.000264	0.000521	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CB—melanoma	0.000263	0.000519	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFRA—melanoma	0.000261	0.000516	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CD80—melanoma	0.000259	0.000511	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKCA—melanoma	0.000259	0.000511	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ITGB3—melanoma	0.000259	0.000511	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—melanoma	0.000258	0.00051	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KIT—melanoma	0.000258	0.00051	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APC—melanoma	0.000258	0.00051	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—NRAS—melanoma	0.000258	0.00051	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGF—melanoma	0.000255	0.000504	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPP1—melanoma	0.000254	0.000501	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAP2K2—melanoma	0.000253	0.000499	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL8—melanoma	0.000253	0.000499	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAPK3—melanoma	0.000247	0.000488	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BRAF—melanoma	0.000243	0.000479	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2—melanoma	0.000241	0.000476	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TERT—melanoma	0.000241	0.000475	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAC1—melanoma	0.00024	0.000473	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—melanoma	0.000237	0.000467	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAPK1—melanoma	0.000235	0.000464	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—melanoma	0.000235	0.000464	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIF1A—melanoma	0.00023	0.000454	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAP2K1—melanoma	0.000229	0.000451	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CD—melanoma	0.000227	0.000448	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—melanoma	0.000225	0.000444	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KRAS—melanoma	0.000222	0.000439	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KDR—melanoma	0.00022	0.000434	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF2—melanoma	0.000217	0.000429	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FN1—melanoma	0.000212	0.000418	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH1—melanoma	0.000207	0.000409	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—melanoma	0.000204	0.000403	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MDM2—melanoma	0.000203	0.000401	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CD80—melanoma	0.000203	0.000401	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—melanoma	0.000203	0.0004	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—melanoma	0.000203	0.0004	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KIT—melanoma	0.000203	0.0004	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—NRAS—melanoma	0.000203	0.0004	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—melanoma	0.000201	0.000396	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGF—melanoma	0.0002	0.000395	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CB—melanoma	0.000198	0.000391	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK3—melanoma	0.000194	0.000383	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BRAF—melanoma	0.000191	0.000376	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—melanoma	0.00019	0.000375	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HRAS—melanoma	0.000189	0.000373	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1B—melanoma	0.000186	0.000367	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—melanoma	0.000186	0.000366	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK1—melanoma	0.000185	0.000364	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—melanoma	0.000185	0.000364	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—melanoma	0.000184	0.000363	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—melanoma	0.000182	0.000359	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—melanoma	0.000182	0.000359	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—melanoma	0.000181	0.000357	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAP2K1—melanoma	0.000179	0.000354	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CD—melanoma	0.000178	0.000352	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—melanoma	0.000177	0.00035	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—melanoma	0.000177	0.000348	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CTNNB1—melanoma	0.000175	0.000346	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—melanoma	0.000174	0.000344	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—melanoma	0.000172	0.000339	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1A—melanoma	0.000171	0.000338	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTEN—melanoma	0.000171	0.000338	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF2—melanoma	0.000171	0.000337	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NFKB1—melanoma	0.00017	0.000336	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—melanoma	0.000167	0.000329	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—melanoma	0.00016	0.000316	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MDM2—melanoma	0.00016	0.000315	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—melanoma	0.000157	0.000311	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CB—melanoma	0.000155	0.000306	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—melanoma	0.000154	0.000305	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—melanoma	0.000153	0.000302	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRAS—melanoma	0.000153	0.000301	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—melanoma	0.000149	0.000295	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRAS—melanoma	0.000148	0.000293	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK3—melanoma	0.000146	0.000288	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1B—melanoma	0.000146	0.000288	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—melanoma	0.000144	0.000285	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—melanoma	0.000143	0.000282	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—melanoma	0.000143	0.000281	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—melanoma	0.000142	0.00028	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—melanoma	0.000142	0.00028	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK1—melanoma	0.000139	0.000274	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—melanoma	0.000139	0.000274	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—melanoma	0.000139	0.000274	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNB1—melanoma	0.000138	0.000272	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—melanoma	0.000135	0.000266	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1A—melanoma	0.000135	0.000265	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—melanoma	0.000134	0.000265	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NFKB1—melanoma	0.000134	0.000264	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—melanoma	0.000131	0.000259	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—melanoma	0.000131	0.000258	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—melanoma	0.000121	0.000239	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—melanoma	0.000121	0.000238	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—melanoma	0.00012	0.000237	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRAS—melanoma	0.00012	0.000236	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—melanoma	0.000117	0.00023	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK3—melanoma	0.000115	0.000226	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRAS—melanoma	0.000112	0.00022	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—melanoma	0.000112	0.00022	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK1—melanoma	0.000109	0.000215	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—melanoma	0.000109	0.000215	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—melanoma	0.000107	0.000211	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—melanoma	0.000103	0.000203	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—melanoma	9.86e-05	0.000195	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—melanoma	9.47e-05	0.000187	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—melanoma	9.16e-05	0.000181	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRAS—melanoma	8.76e-05	0.000173	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—melanoma	8.38e-05	0.000165	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—melanoma	7.74e-05	0.000153	CbGpPWpGaD
